tetano
Editor, Senior Moderator
Sci Rep
. 2026 Jun 12.
doi: 10.1038/s41598-026-55080-0. Online ahead of print.
Clinical and genomic characterization of Influenza A co-infection with SARS-CoV-2 and Influenza B: a respiratory surveillance study in Assam, India
Neelanjana Sarmah[SUP] 1 [/SUP], Aktarul Islam Siddique[SUP] 1 [/SUP], Mousumi Dutta[SUP] 1 [/SUP], Aniruddha Jakharia[SUP] 1 [/SUP], Nargis Bali[SUP] 2 [/SUP], Neetu Vijay[SUP] 3 [/SUP], Nivedita Gupta[SUP] 4 [/SUP], Suman Kanungo[SUP] 1 [/SUP], Biswajyoti Borkakoty[SUP] 5 [/SUP]
Affiliations
Influenza and SARS-CoV-2 are the primary contributors to seasonal respiratory infections and frequently co-circulate, creating significant health challenges. The present respiratory surveillance study was conducted in Dibrugarh, Assam, India from January 2025 to August 2025 to investigate the genomic characteristics of circulating viruses and identify potential co-infections. Overall, 4,948 respiratory samples were screened using multiplex real-time PCR, followed by subtyping of Influenza A and Influenza B. Next-generation sequencing (NGS) was performed in selected positives of SARS-CoV-2 and Influenza A. Genomic analysis included mutational profiling, phylogenetic analysis and N-glycosylation site prediction using bioinformatics tools. Two co-infection cases were detected: one involving Influenza A (H3N2) with SARS-CoV-2 (Omicron XFG lineage) and another involving Influenza A (H3N2) with Influenza B (Victoria lineage). Both patients experienced mild illness without hospitalisation. NGS revealed that the Influenza A (H3N2) viruses belonged to clade 3C.2a1b.2a.2a.3a.1 while SARS-CoV-2 sequence was classified under the Omicron XFG lineage. Mutational analysis of the HA gene showed several amino acid differences compared to the reference vaccine strain A/Darwin/6/2021. N-glycosylation analysis predicted conserved sites at positions 79, 181, 262, and 301 in all strains along with an additional predicted site at position 110 in both co-infection cases. Although the co-infection cases presented with mild clinical manifestations, the observed genomic variations indicate a potential role of co-infecting viruses in shaping viral evolution. Given the limited genomic data available from Northeast India, the study underscores the need for sustained large scale follow up and genomic surveillance to monitor emerging mutations and target future vaccine strategies.
Keywords: ARI; Co-infection; Influenza A (H3N2); Influenza B (Victoria); SARI; SARS-CoV-2.
. 2026 Jun 12.
doi: 10.1038/s41598-026-55080-0. Online ahead of print.
Clinical and genomic characterization of Influenza A co-infection with SARS-CoV-2 and Influenza B: a respiratory surveillance study in Assam, India
Neelanjana Sarmah[SUP] 1 [/SUP], Aktarul Islam Siddique[SUP] 1 [/SUP], Mousumi Dutta[SUP] 1 [/SUP], Aniruddha Jakharia[SUP] 1 [/SUP], Nargis Bali[SUP] 2 [/SUP], Neetu Vijay[SUP] 3 [/SUP], Nivedita Gupta[SUP] 4 [/SUP], Suman Kanungo[SUP] 1 [/SUP], Biswajyoti Borkakoty[SUP] 5 [/SUP]
Affiliations
- PMID: 42286013
- DOI: 10.1038/s41598-026-55080-0
Influenza and SARS-CoV-2 are the primary contributors to seasonal respiratory infections and frequently co-circulate, creating significant health challenges. The present respiratory surveillance study was conducted in Dibrugarh, Assam, India from January 2025 to August 2025 to investigate the genomic characteristics of circulating viruses and identify potential co-infections. Overall, 4,948 respiratory samples were screened using multiplex real-time PCR, followed by subtyping of Influenza A and Influenza B. Next-generation sequencing (NGS) was performed in selected positives of SARS-CoV-2 and Influenza A. Genomic analysis included mutational profiling, phylogenetic analysis and N-glycosylation site prediction using bioinformatics tools. Two co-infection cases were detected: one involving Influenza A (H3N2) with SARS-CoV-2 (Omicron XFG lineage) and another involving Influenza A (H3N2) with Influenza B (Victoria lineage). Both patients experienced mild illness without hospitalisation. NGS revealed that the Influenza A (H3N2) viruses belonged to clade 3C.2a1b.2a.2a.3a.1 while SARS-CoV-2 sequence was classified under the Omicron XFG lineage. Mutational analysis of the HA gene showed several amino acid differences compared to the reference vaccine strain A/Darwin/6/2021. N-glycosylation analysis predicted conserved sites at positions 79, 181, 262, and 301 in all strains along with an additional predicted site at position 110 in both co-infection cases. Although the co-infection cases presented with mild clinical manifestations, the observed genomic variations indicate a potential role of co-infecting viruses in shaping viral evolution. Given the limited genomic data available from Northeast India, the study underscores the need for sustained large scale follow up and genomic surveillance to monitor emerging mutations and target future vaccine strategies.
Keywords: ARI; Co-infection; Influenza A (H3N2); Influenza B (Victoria); SARI; SARS-CoV-2.